February 2, 2023
ICER’s cost-effectiveness analysis doesn’t wholly depict
the value of new Alzheimer’s medications.
February 2, 2023
ICER released its draft evidence report on beta-amyloid antibodies for early Alzheimer’s disease.
January 25, 2023
From difficult symptoms to an accurate diagnosis to effective treatment, the rare disease journey is a long one. But despite the challenges patients face, innovation and education are regularly improving lives.
January 11, 2023
RSV, or respiratory syncytial virus, is a common, highly contagious seasonal virus that affects 97% of children by the age of 2.
January 4, 2023
Alzheimer’s disease and other forms of dementia have long impacted families
and communities across the country. Today, about 6 million Americans live
with Alzheimer’s disease — a number that will more than double by 2050.
December 19, 2022
The seventh annual National Policy & Advocacy Summit on Biologics brought together health care providers, policy experts, patient advocates and other stakeholders.
December 19, 2022
At some point in their lives, most patients encounter insurance delays or denials for a prescription medication. But do certain groups of patients encounter these barriers more often than others? And at what cost?
December 5, 2022
Headache and migraine patients’ choice of treatment options is narrowing as health plans exclude coverage for more medications and devices.
November 28, 2022
Daily life can be difficult for people with Parkinson’s, a relentlessly progressive neurodegenerative disease that affects both movement and cognition.
November 28, 2022
Healthy employees make for a healthy organization. As you explore health insurance options for your employees, consider these five tips.
